These four SNPs exhibited a dominant mode of genotypic association with dyslipidemia, which implies that the BUD13, ZPR1 and APOA5-APOA4 intergenic regions might have a direct role in regulating these traits through their pleiotropic effects. This evidence concerns the gene ZPR1 and metabolic syndrome.